Incretin Mimetics Market Size Worth $70 Billion By 2030: IndustryARC bignewsnetwork.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bignewsnetwork.com Daily Mail and Mail on Sunday newspapers.
Tirzepatide is superior to Semaglutide in reducing HbA1c levels and preventing hypoglycemia. ‘Weight-loss surgery will be a thing of the past, it will be out of the medical books even,’ says Prof Surender Kumar, Dept of Endocrinology and Metabolism, Sir Ganga Ram Hospital, Delhi